OCC 1.25% 39.5¢ orthocell limited

Ann: Quarterly Activity Report & Appendix 4C, page-46

  1. 7,518 Posts.
    lightbulb Created with Sketch. 6772
    Veritas evaluation was far more impressive and on the ball and created little. We also know share price and volumes spike on any reported good news. The Appendix 4C showed much higher sales. As said above, Even using a lowly $80 and $800, the 4QFY23 known accrued sales (that preclude non-BH/DVT sales) give $728,160 quarterly revenue (5,482 Straite x $80 plus 362 Remplir x $800).

    The coming earnings have to be an upside surprise on accrual accounting on the much higher sales vs the cash flow that did not reflect the same gains.
    Last edited by bedger: 14/08/23
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
39.5¢
Change
-0.005(1.25%)
Mkt cap ! $82.68M
Open High Low Value Volume
40.0¢ 40.0¢ 39.0¢ $65.71K 166.2K

Buyers (Bids)

No. Vol. Price($)
1 1052 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 354895 8
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.